Exploring Drugs and Vaccines Associated with Altered Risks and Severity of COVID-19: A UK Biobank Cohort Study of All ATC Level-4 Drug Categories Reveals Repositioning Opportunities

Effective therapies for COVID-19 are still lacking, and drug repositioning is a promising approach to address this problem. Here, we adopted a medical informatics approach to repositioning. We leveraged a large prospective cohort, the UK-Biobank (UKBB, N ~ 397,000), and studied associations of prior...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Yong, Wong, Kenneth Chi-Yin, So, Hon-Cheong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471264/
https://www.ncbi.nlm.nih.gov/pubmed/34575590
http://dx.doi.org/10.3390/pharmaceutics13091514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471264/
https://www.ncbi.nlm.nih.gov/pubmed/34575590
http://dx.doi.org/10.3390/pharmaceutics13091514

Ejemplares similares